Saffron Memory v3
Natural health product licensed in Canada
- Other names
- Better Memory, Memory, Saffron Memory
- Licence holder
- Genuine Health Inc.
- NPN or DIN-HM
- 80121740
- Status
- Active licence
- Licence date
- 28 October 2022
- Revision date
- 18 September 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Crocus sativus Source : Crocus sativus - Stigmate Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 42 mg Potency : 3.48 % Crocin | 14 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 3 g Potency : 24 % Flavonoid glycosides | 60 mg | Not calculated |
| Salvia officinalis Source : Salvia officinalis - Feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 6 g | 300 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Hypromellose, Amidon prégélatinisé, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to enhance cognitive function in adults. Helps to enhance memory in adults. Helps to support peripheral circulation. Source of/Provides antioxidants. Helps to support mood balance. affron helps to relieve restlessness and/or nervousness (calmative). Supports positive effects on symptoms of perceived stress such as, fatigue, weariness, and irritability. Helps to reduce the symptoms of perceived stress, such as fatigue, weariness, and irritability. Helps to improve restorative sleep in individuals experiencing sleeplessness. Helps improve sleep quality in individuals experiencing sleeplessness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80121740
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging